For the year ending 2025-12-31, IMNM made $6,941K in revenue. -$212,394K in net income. Net profit margin of -3059.99%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Collaboration revenue | 6,941 | |||
| In-process research and development | 10,000 | |||
| Research and development | 177,286 | |||
| General and administrative | 43,768 | |||
| Total operating expenses | 231,054 | |||
| Loss from operations | -224,113 | |||
| Interest income | 11,719 | |||
| Net loss | -212,394 | |||
| Basic EPS | -2.43 | |||
| Diluted EPS | -2.43 | |||
| Basic Average Shares | 87,350,956 | |||
| Diluted Average Shares | 87,350,956 | |||
Immunome Inc. (IMNM)
Immunome Inc. (IMNM)